Target intelligence / Profile preview

Taurine pathway

Molecular classification
Other (Metabolic pathway, not a single molecule)
01

Overview

The taurine pathway refers to the network of biochemical reactions that synthesize, transport, and metabolize taurine, a sulfur-containing beta-amino acid involved in numerous physiological processes, including osmoregulation, antioxidative defense, modulation of calcium signaling, and conjugation of bile acids[1][5]. Taurine is synthesized primarily from cysteine via the cysteine sulfinic acid pathway, and its levels are maintained by both endogenous synthesis and transport via the high-affinity taurine transporter (TauT/SLC6A6)[1][3]. Pathway components, especially the taurine transporter and various biosynthetic enzymes, play critical roles in physiology and in the pathology of certain diseases, but "taurine pathway" as a whole is not a classical therapeutic target[3][4][5].

Other names
Taurine biosynthesis pathwayTaurine metabolic pathway
02

Mechanism of action

Antioxidant activity Calcium channel inhibition Suppression of ER stress pathways Regulation of cellular osmosis Regulation of mitochondrial function Inhibition of pro-inflammatory and pro-apoptotic signaling

03

Biological functions

Taurine biosynthesisTaurine transportModulation of cellular redox and antioxidant defenseRegulation of bile acid conjugationOsmoregulationNeuromodulation
04

Disease associations

Neurodegenerative disease (altered taurine metabolism implicated in conditions such as stroke, Alzheimer’s, Huntington’s, Parkinson’s)Cardiovascular disease (role in congestive heart failure and atherosclerosis)Inflammation (rheumatoid arthritis, anti-inflammatory effects)Cancer (taurine levels correlate with prognosis in certain cancers)Mitochondrial diseases (e.g., MELAS)Diabetes
05

Safety considerations

Generally considered safe; high supplementation is well-tolerated but safety long-term at pharmacologic doses is not fully knownNo major specific drug pathway-related toxicities reported
06

Interacting drugs

Taurine (administered as a supplement/therapeutic agent)

2 more in the full profile.

07

Biomarkers

Taurine levels in plasma or tissue (for monitoring metabolic state or disease risk/progression)

Beyond the preview

Go deeper on Taurine pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taurine pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call